Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response (Q34988055)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response |
scientific article |
Statements
1 reference
Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response (English)
1 reference
Zhigang Kang
1 reference
Jun-Jie Chen
1 reference
Yunkai Yu
1 reference
Bo Li
1 reference
Shi-Yong Sun
1 reference
Baolin Zhang
1 reference
Liang Cao
1 reference
8 March 2011
1 reference
1 reference
17
1 reference
10
1 reference
3181-3192
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference